A four-group urine risk classifier for predicting outcomes in patients with prostate cancer-Reference-Cited by-同舟云学术

A four-group urine risk classifier for predicting outcomes in patients with prostate cancer

Published:2019-06-25 Issue:4 Volume:124 Page:609-620
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Connell Shea P.¹^ORCID,Yazbek-Hanna Marcelino¹,McCarthy Frank²,Hurst Rachel¹,Webb Martyn¹,Curley Helen¹,Walker Helen³,Mills Rob³,Ball Richard Y.³,Sanda Martin G.⁴,Pellegrini Kathryn L.⁴,Patil Dattatraya⁴,Perry Antoinette S.⁵,Schalken Jack⁶,Pandha Hardev⁷,Whitaker Hayley⁸^ORCID,Dennis Nening²,Stuttle Christine²,Mills Ian G.⁹¹⁰¹¹,Guldvik Ingrid¹⁰,Parker Chris¹²,Brewer Daniel S.¹¹³,Cooper Colin S.¹,Clark Jeremy¹,

Affiliation:

1. Norwich Medical School; University of East Anglia; Norwich UK

2. Institute of Cancer Research; Sutton UK

3. Norfolk and Norwich University Hospitals NHS Foundation Trust; Norwich UK

4. Department of Urology; Winship Cancer Institute; Emory University School of Medicine; Atlanta GA USA

5. School of Biology and Environmental Science; Science West; University College Dublin; Dublin 4 Ireland

6. Nijmegen Medical Centre; Radboud University Medical Centre; Nijmegen The Netherlands

7. Faculty of Health and Medical Sciences; The University of Surrey; Guildford UK

8. Molecular Diagnostics and Therapeutics Group; University College London; London UK

9. School of Medicine; Dentistry and Biomedical Sciences; Institute for Health Sciences; Centre for Cancer Research and Cell Biology; Queen's University Belfast; Belfast UK

10. Centre for Molecular Medicine; University of Oslo; Oslo Norway

11. Nuffield Department of Surgical Sciences; University of Oxford; Oxford UK

12. Royal Marsden Hospital; Sutton UK

13. Earlham Institute; Norwich UK

Funder

Movember Foundation GAP1 Urine Biomarker Project

Masonic Charitable Foundation

Bob Champion Cancer Trust

King family

Andy Ripley Memorial Fund

Stephen Hargrave Trust

Publisher